Pharmaceuticals in (sea)water new development exercise DE-19
In May 2021, Quasimeme held a survey amongst the participants, suggestions for new exercises were made. Quasimeme used these suggestions to conduct a survey among the respondents. As a result Quasimeme is starting a development exercise specifically for Pharmaceuticals in (sea)water.
Pharmaceuticals residues occur globally in the aquatic environment and can have adverse effects on the environment. Much research has been done to analyze these pharmaceuticals and to understand the impact. Proficiency tests have been developed for pharmaceuticals, however, not specifically for estuarine, coastal and ocean water.
As laboratories are interested in a proficiency test using (sea)water, Quasimeme is starting a development exercise primarily focusing on two non-steroidal anti-inflammatory drugs (NSAID’s: diclofenac and ibuprofen), one anti-convulsant (carbamazepine) and three anti-biotics (azithromycin, clarithromycin and erythromycin).
Quasimeme invites everyone interested in this exercise to get in touch with us via email and to join our discussion platform on LinkedIn.